Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With eMDRs On The Way, Many Firms Are Updating Complaint Handling Systems

This article was originally published in The Gray Sheet

Executive Summary

Some manufacturers are using the advent of FDA’s electronic Medical Device Reporting (eMDR) program as an opportunity to upgrade their complaint handling systems.

You may also be interested in...



FDA Requires Electronic Submission Of Adverse Event Reports By August 2015

The new regulation applies to all device manufacturers and importers, regardless of their size. FDA increased its previously proposed one-year compliance window to 18 months in response to company input.

FDA Post-Market Plan Gains Support, But Many Details Still Lacking

A diverse set of stakeholders backed FDA’s new proposed national post-market surveillance plan during a series of public meetings last week, but participants warned “the devil is in the details.”

Patients Should Play Bigger Role In Adverse Event Reporting: AHRQ

Because patients have a perspective on the health care system that providers do not necessarily share, greater efforts should be made to obtain adverse event information directly from them, according to the Agency for Healthcare Research and Quality.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel